Yu Deng

14.5k citations
159 papers · 7.7k indexed · 4 hit papers · h-index 35

Impact in

Papers in

Yu Deng

152 papers receiving 7.6k citations

Hit Papers

Updated Overall Survival and PD-L1 Subgroup Analysis of Patients With Extensive-Stage Small-Cell Lung Cancer Treated With Atezolizumab, Carboplatin, and Etoposide (IMpower133) 2021 · 484 citations
484201820262020202350010001.5k2.0k2.5k

Peers

Yu Deng
Comparison fields: 5 of 143
  • Oncology 3.8k
  • Pulmonary and Respiratory Medicine 2.5k
  • Cancer Research 1.1k
  • Health, Toxicology and Mutagenesis 767
  • Immunology 881
Replace Bart van de Sluis with:
Bart van de Sluis Netherlands
Bei Sun China
Kathryn M. Lemberg United States
Tetsuya Taguchi Japan
Shougang Zhuang United States
Antonino Belfiore Italy
Andras J. Bauer United States
Matías A. Ávila Spain
Ying Xin China
Shuhei Tomita Japan
Yu Deng relative to Bart van de Sluis Netherlands Bart van de Sluis's profile →
Citations per field
00.5×7.9×
Bart van de Sluis · 1×
Citations per year

Countries citing papers authored by Yu Deng

Since Specialization
Citations

This map shows the geographic impact of Yu Deng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu Deng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu Deng more than expected).

Fields of papers citing papers by Yu Deng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu Deng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu Deng. The network helps show where Yu Deng may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Yu Deng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Yu Deng Line = papers co-authored together Yu Deng links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20251
2 20253
3 20250
4 202329
5 202310
6 20237
7 20237
8 20238
9 202214
10 20224
11 202216
12 20227
13 20228
14 202217
15
Updated Overall Survival and PD-L1 Subgroup Analysis of Patients With Extensive-Stage Small-Cell Lung Cancer Treated With Atezolizumab, Carboplatin, and Etoposide (IMpower133)
Hit paper breakdown →
2021484
16 202111
17 202016
18 201928
19 201837
20
Electro-oculogram of retinal vein occlusion.
19942

About Yu Deng

Yu Deng is a scholar working on Health, Toxicology and Mutagenesis, Developmental Neuroscience, Nutrition and Dietetics, Geriatrics and Gerontology and Cellular and Molecular Neuroscience, having authored 159 papers that have together received 7.7k indexed citations. Recurring topics across this work include Heavy Metal Exposure and Toxicity (38 papers), Mercury impact and mitigation studies (22 papers), Neuroscience and Neuropharmacology Research (20 papers), Autophagy in Disease and Therapy (20 papers), Trace Elements in Health (17 papers), RNA modifications and cancer (15 papers), Heme Oxygenase-1 and Carbon Monoxide (11 papers) and Alzheimer's disease research and treatments (11 papers). The work is most often cited by research in Oncology (3.8k citations), Pulmonary and Respiratory Medicine (2.5k citations), Cancer Research (1.1k citations), Health, Toxicology and Mutagenesis (767 citations) and Immunology (881 citations). Yu Deng has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Bin Xu, Zhaofa Xu, Francesco Orlandi, Marcin Kowanetz, Anthony Lee, Martin Reck, Denis Moro‐Sibilot, Fabrice Barlési, Naoyuki Nogami and Daniil Stroyakovskiy. Their work appears in journals such as Environmental Toxicology, Molecular Neurobiology, Biological Trace Element Research, The Science of The Total Environment and Food and Chemical Toxicology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026